Tumati, S., Largent-Milnes, T. M., Keresztes, A., Ren, J., Roeske, W. R., Vanderah, T. W., & Varga, E. V. (2012). Repeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by co-administration of a selective cannabinoid receptor type-2 agonist.
Citação norma ChicagoTumati, Suneeta, Tally M. Largent-Milnes, Attila Keresztes, Jiyang Ren, William R. Roeske, Todd W. Vanderah, and Eva V. Varga. Repeated Morphine Treatment-mediated Hyperalgesia, Allodynia and Spinal Glial Activation Are Blocked By Co-administration of a Selective Cannabinoid Receptor Type-2 Agonist. 2012.
MLA citiranjeTumati, Suneeta, et al. Repeated Morphine Treatment-mediated Hyperalgesia, Allodynia and Spinal Glial Activation Are Blocked By Co-administration of a Selective Cannabinoid Receptor Type-2 Agonist. 2012.